Pharma-Bio Serv, Inc. (PBSV)

Market Cap	11.22M -41.9%
Revenue (ttm)	9.00M -5.3%
Net Income	-100.46K
EPS	-0.00
Shares Out	22.90M
PE Ratio	n/a
Forward PE	4.45
Dividend	0.08 (15.31%)
Ex-Dividend Date	Feb 27, 2026

Volume	900
Average Volume	6,618
Open	0.4900
Previous Close	0.5900
Day's Range	0.4900 - 0.4900
52-Week Range	0.3451 - 1.3600
Beta	0.78
RSI	38.81
Earnings Date	Mar 17, 2026

About Pharma-Bio Serv

Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companie...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1993
• Employees: 55
• Stock Exchange: OTCMKTS
• Ticker Symbol: PBSV

Financial Performance

In fiscal year 2025, Pharma-Bio Serv's revenue was $9.00 million, a decrease of -5.34% compared to the previous year's $9.51 million. Losses were -$100,463, -87.08% less than in 2024.